Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.013
Neutral
RSI(14)
38.062
Neutral
STOCH(KDJ)(9,3,3)
32.903
Neutral
ATR(14)
0.081
High Vlolatility
CCI(14)
-141.510
Sell
Williams %R
55.842
Sell
TRIX(12,20)
-0.937
Sell
StochRSI(14)
59.450
Buy
Search
Firefly Neuroscience Inc
AIFFAdd to Watchlist
1.070USD
+0.060+5.94%
Close 07-31 16:00（ET）Quotes delayed by 15 min
15.91MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+5.94%
5 Days
-3.60%
1 Month
-11.57%
6 Months
+22.30%
Year to Date
+22.29%
1 Year
-61.51%
Key Figures
1.010Open
1.080High
66.47KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.45%Turnover Ratio
1.010Prev. Close
1.010Low
51.11KTurnover
LossP/E Static
1.88P/B
0.00%Div Yield TTM
-76.96%ROA
4.51052wk High
0.44Volume Ratio
-10.46MNet Profit
14.87MShares
-0.3589EPS TTM
0.08Beta
-136.27%ROE
0.61852wk Low
6.93%Amplitude
45.57%Gross Margin
15.91MMarket Cap
-3.21Reward/Risk
6.76%Risk Rate
TradingKey Stock Score of Firefly Neuroscience Inc
Currency: USD Updated: 2026-07-31Key Insights
Firefly Neuroscience Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 231 out of 485 in the Software & IT Services industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Firefly Neuroscience Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Firefly Neuroscience Inc Highlights
StrengthsRisks
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.14M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.14M.
Undervalued
The company’s latest PE is -2.98, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.05M shares, decreasing 41.27% quarter-over-quarter.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Firefly Neuroscience Inc News
More news coming soon, stay tuned...
Indicators
Moving Average
Indicators
Value
Direction
MA5
1.087
Sell
MA10
1.105
Sell
MA20
1.146
Sell
MA50
1.373
Sell
MA100
1.671
Sell
MA200
1.512
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Firefly Neuroscience Inc Info
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
Ticker SymbolAIFF
CompanyFirefly Neuroscience Inc
CEOLipschitz (Greg)
Websitehttps://fireflyneuro.com/
Shareholders
Related Instruments
-4.29%
+6.88%
+6.73%
+3.02%
+3.28%
-0.03%
-0.72%
+1.82%
-2.00%
+0.65%
+5.12%
+1.89%
+1.57%
+0.92%
+3.04%
+1.89%
+0.07%
-1.97%
+1.28%
+4.99%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Firefly Neuroscience Inc (AIFF)?
The current price of Firefly Neuroscience Inc (AIFF) is 1.06.
What is the symbol of Firefly Neuroscience Inc?
The ticker symbol of Firefly Neuroscience Inc is AIFF.
What is the 52-week high of Firefly Neuroscience Inc?
The 52-week high of Firefly Neuroscience Inc is 4.51.
What is the 52-week low of Firefly Neuroscience Inc?
The 52-week low of Firefly Neuroscience Inc is 0.62.
What is the market capitalization of Firefly Neuroscience Inc?
The market capitalization of Firefly Neuroscience Inc is 15.83M.
What is the Earnings Per Share (EPS TTM) of Firefly Neuroscience Inc (AIFF)?
The Earnings Per Share (EPS TTM) of Firefly Neuroscience Inc (AIFF) is -1.97.